Long-Term Survival and Late Effects among One-Year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic Syndromes

Christine N. Duncan, Navneet S. Majhail*, Ruta Brazauskas, Zhiwei Wang, Jean-Yves Cahn, Haydar A. Frangoul, Robert J. Hayashi, Jack W. Hsu, Rammurti T. Kamble, Kimberly A. Kasow, Nandita Khera, Hillard M. Lazarus, Alison W. Loren, David I. Marks, Richard T. Maziarz, Paulette Mehta, Kasiani C. Myers, Maxim Norkin, Joseph A. Pidala, David L. PorterVijay Reddy, Wael Saber, Bipin N. Savani, Harry C. Schouten, Amir Steinberg, Donna A. Wall, Anne B. Warwick, William A. Wood, Lolie C. Yu, David A. Jacobsohn, Mohamed L. Sorror

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)151-158
JournalBiology of Blood and Marrow Transplantation
Volume21
Issue number1
DOIs
Publication statusPublished - Jan 2015

Keywords

  • Hematopoietic cell transplantation
  • Allogeneic transplantation
  • Second transplantation
  • Long-term survival
  • Late effects

Cite this